Academic Content and Language Evaluation of This Article
CrossCheck and Google Search of This Article
Academic Rules and Norms of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (8137)
All Articles published online
|
Publishing Process of This Article
|
Aug 7, 2016 (publication date) through Nov 22, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Jiménez-Pérez M, González-Grande R, España Contreras P, Pinazo Martínez I, de la Cruz Lombardo J, Olmedo Martín R. Treatment of chronic hepatitis C with direct-acting antivirals: The role of resistance. World J Gastroenterol 2016; 22(29): 6573-6581 [PMID: 27547001 DOI: 10.3748/wjg.v22.i29.6573] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v22/i29/6573.htm |
| Number | Citing Articles |
| 1 |
Václav Vopálenský, Anas Khawaja, Luděk Rožnovský, Jakub Mrázek, Tomáš Mašek, Martin Pospíšek. Characterization of Hepatitis C Virus IRES Quasispecies – From the Individual to the Pool. Frontiers in Microbiology 2018; 9 doi: 10.3389/fmicb.2018.00731
|
| 2 |
Andréa Monteiro Tarragô, Grenda Leite Pereira, Flamir da Silva Victória, Adriana Malheiro Alle Marie, Marilú Barbieri Victória. Sofosbuvir and daclatasvir combination therapy for current hepatitis C virus genotype 4 achieves SVR: a case report of HCV genotype 4 from the Amazon. Revista da Sociedade Brasileira de Medicina Tropical 2017; 50(6): 861 doi: 10.1590/0037-8682-0094-2017
|
| 3 |
Francesca Romana Ponziani, Francesca Mangiola, Cecilia Binda, Maria Assunta Zocco, Massimo Siciliano, Antonio Grieco, Gian Lodovico Rapaccini, Maurizio Pompili, Antonio Gasbarrini. Future of liver disease in the era of direct acting antivirals for the treatment of hepatitis C. World Journal of Hepatology 2017; 9(7): 352-367 doi: 10.4254/wjh.v9.i7.352
|
| 4 |
Ana Paula de Torres Santos, Vanessa Cristina Martins Silva, Maria Cássia Mendes-Corrêa, Marcilio Figueiredo Lemos, Fernanda de Mello Malta, Rúbia Anita Ferraz Santana, Gregório Tadeu Fernando Dastoli, Vanessa Fusco Duarte de Castro, João Renato Rebello Pinho, Regina Célia Moreira. Characterization of primary direct-acting antiviral (DAA) drugs resistance mutations in NS5A/NS5B regions of hepatitis C virus with genotype 1a and 1b from patients with chronic hepatitis. Revista do Instituto de Medicina Tropical de São Paulo 2022; 64 doi: 10.1590/s1678-9946202264061
|
| 5 |
Charlotte M. Page, Brenna L. Hughes, Eleanor H.J. Rhee, Jeffrey A. Kuller. Hepatitis C in Pregnancy: Review of Current Knowledge and Updated Recommendations for Management. Obstetrical & Gynecological Survey 2017; 72(6): 347 doi: 10.1097/OGX.0000000000000442
|
| 6 |
J.‐F. Jiang, J. Sun, J. Shi, X. Liu. Letter: should direct‐acting antiviral drugs be used concomitantly with chemotherapeutic drugs in hepatitis C virus‐infected patients with cancer?. Alimentary Pharmacology & Therapeutics 2017; 45(5): 757 doi: 10.1111/apt.13918
|
| 7 |
Cecilia Trucchi, Andrea Orsi, Cristiano Alicino, Laura Sticchi, Giancarlo Icardi, Filippo Ansaldi. State of the Art, Unresolved Issues, and Future Research Directions in the Fight against Hepatitis C Virus: Perspectives for Screening, Diagnostics of Resistances, and Immunization. Journal of Immunology Research 2016; 2016: 1 doi: 10.1155/2016/1412840
|
| 8 |
Brenna L. Hughes, Charlotte M. Page, Jeffrey A. Kuller. Hepatitis C in pregnancy: screening, treatment, and management. American Journal of Obstetrics and Gynecology 2017; 217(5): B2 doi: 10.1016/j.ajog.2017.07.039
|
| 9 |
Jian-Hong Chen, Zheng Zeng, Xia-Xia Zhang, Yu Zhang, Ren-Wen Zhang, Shuai Wang, Chi-Hong Wu, Min Yu, Dan Liu, Hong-Li Xi, Yi-Xing Zhou, Yao-Yu An, Xiao-Yuan Xu. Efficacy and safety of combined directly acting antivirals for treatment of Chinese chronic hepatitis C patients in a real-world setting. World Journal of Gastroenterology 2017; 23(22): 4072-4079 doi: 10.3748/wjg.v23.i22.4072
|
| 10 |
Hassan M. Moukhadder, Racha Halawi, Maria Domenica Cappellini, Ali T. Taher. Hepatocellular carcinoma as an emerging morbidity in the thalassemia syndromes: A comprehensive review. Cancer 2017; 123(5): 751 doi: 10.1002/cncr.30462
|
| 11 |
Patricia Anne O’Malley. The Ethics, Cost, and Evidence Surrounding Current Pharmacological Treatment of Hepatitis C Virus Infection. Clinical Nurse Specialist 2017; 31(4): 186 doi: 10.1097/NUR.0000000000000311
|
| 12 |
Saima Mushtaq, Asraf Hussain Hashmi, Amjad Khan, Syed Muhammad Asad Raza Kazmi, Sobia Manzoor. Emergence and Persistence of Resistance-Associated Substitutions in HCV GT3 Patients Failing Direct-Acting Antivirals. Frontiers in Pharmacology 2022; 13 doi: 10.3389/fphar.2022.894460
|
| 13 |
Jianhong Chen, Xiaxia Zhang, Hao Luo, Chihong Wu, Min Yu, Dan Liu, Hongli Xi, Yihang Zhou, Yaoyu An, Xiaoyuan Xu. Changes in renal function indices in cirrhotic chronic hepatitis C patients treated with sofosbuvir-containing regimens. Oncotarget 2017; 8(53): 90916 doi: 10.18632/oncotarget.18701
|
| 14 |
Talita Rocha Passos, Fabiana Silva Santos, Maria Cleusa Martins, Vanusa Barbosa Pinto, Flair José Carrilho, Suzane Kioko Ono. Clinical pharmacology profile of care in Hepatology clinic. Revista da Associação Médica Brasileira 2017; 63(5): 401 doi: 10.1590/1806-9282.63.05.401
|
| 15 |
Yosuke Hashimoto, Masayoshi Fukasawa, Hiroki Kuniyasu, Kiyohito Yagi, Masuo Kondoh. Claudin‐targeted drug development using anti‐claudin monoclonal antibodies to treat hepatitis and cancer. Annals of the New York Academy of Sciences 2017; 1397(1): 5 doi: 10.1111/nyas.13337
|
| 16 |
Maliha Naseer, Harleen Chela, Alhareth AlJuboori. Viral Hepatitis: Chronic Hepatitis C. 2019; : 25 doi: 10.1007/978-3-030-03757-4_2
|
| 17 |
Sandra Abdul Massih, Ahizechukwu C. Eke. Direct antiviral agents (DAAs) and their use in pregnant women with hepatitis C (HCV). Expert Review of Anti-infective Therapy 2022; 20(11): 1413 doi: 10.1080/14787210.2022.2125868
|
| 18 |
Mohamed AbdAllah, Mohamed Alboraie, Wael Abdel‐Razek, Mohamed Hassany, Islam Ammar, Ehab Kamal, Mahmoud Alalfy, Ahmed Okasha, Wafaa El Akel, Elsaied Shaaban, Tamer Elbaz, Zeinab Hefny, Ahmed Gomaa, Mahmoud El‐Bendary, Magdy El‐Serafy, Gamal Esmat, Wahid Doss, Manal H El‐Sayed. Pregnancy outcome of anti‐HCV direct‐acting antivirals: Real‐life data from an Egyptian cohort. Liver International 2021; 41(7): 1494 doi: 10.1111/liv.14913
|
| 19 |
Eman Raslan, Mohamed AbdAllah, Saeed Soliman. The prevalence and determinants of hepatitis B among Egyptian adults: a further analysis of a country-representative survey. Egyptian Liver Journal 2022; 12(1) doi: 10.1186/s43066-022-00207-x
|
| 20 |
Pierina D’Angelo, Rossana Celeste Jaspe, Carmen Luisa Loureiro, Cristina Gutiérrez, María Zulay Sulbarán, Yoneira Sulbarán, Felix Toro, Flor Helene Pujol. Desempeño de métodos moleculares para la identificación de subtipos poco comunes del virus de hepatitis C genotipo 2. Biomédica 2018; 38(2): 282 doi: 10.7705/biomedica.v38i0.3864
|
| 21 |
Catalina Iulia Saveanu, Gianina Dărăbăneanu, Livia Ionela Bobu, Daniela Anistoroaei, Irina Bamboi, Irina Ciortescu, Alexandra Ecaterina Saveanu. A Cross-Sectional Questionnaire-Based Survey on Blood-Borne Infection Control among Romanian Dental Students. Medicina 2022; 58(9): 1268 doi: 10.3390/medicina58091268
|